News

News | June 3, 2019

Carisma Therapeutics Names Dr. Robert Petit As Chief Scientific Officer

Read More

News | May 27, 2019

Carisma Therapeutics Featured in Nature Biotechnology’s Top Academic Spin-outs 2018

Read More

Press Release | May 14, 2019

Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer

Read More

News | March 1, 2019

Genome editing company Precision proposes $100M IPO

Read More

Press Release | January 4, 2019

Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

Read More

News | December 18, 2018

Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita

Read More

Press Release | December 13, 2018

Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

Read More

Press Release | December 6, 2018

Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

Read More

News | November 27, 2018

Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy

Read More

News | November 20, 2018

Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

Read More